Advertisement
Screener

AMICUS THERAPEUTICS, INC. Patents: Applications Pending

AMICUS THERAPEUTICS, INC. Patent Applications Pending

85 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-09-22: Application 19335590; Invention High Concentration Alpha-Glucosidase Compositions For The Treatment Of Pompe Disease; Applicant Amicus Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
  • 2025-09-19: Application 19333835; Invention METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING RENAL IMPAIRMENT; Applicant Amicus Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
  • 2025-09-15: Application 19328687; Invention Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA Gene; Applicant Amicus Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
  • 2025-07-11: Application 19147498; Invention Gene Therapy Constructs for the Treatment of Pompe Disease; Applicant Amicus Therapeutics, Inc.; Status Application Undergoing Preexam Processing.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2025-09-2219335590High Concentration Alpha-Glucosidase Compositions For The Treatment Of Pompe DiseaseAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260083829A1
Kenneth Valenzano
John Crowley
Richie Khanna
John Flanagan
United States
United States
United States
United States
CENTRAL, DOCKET
2025-09-1919333835METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING RENAL IMPAIRMENTAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260076951A1
Franklin Johnson
United States
CENTRAL, DOCKET
2025-09-1519328687Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA GeneAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260240829A1
Elfrida Benjamin
United States
CENTRAL, DOCKET
2025-07-1119147498Gene Therapy Constructs for the Treatment of Pompe DiseaseAmicus Therapeutics, Inc.Application Undergoing Preexam ProcessingUS20260216373A1
Hung V. Do
United States
2025-06-26PCTUS2025035523NITROSAMINE COMPOUNDS AND METHODS FOR ANALYZING THE SAMEAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
MOHAMMED SHEIKH SHEIKH
United States
2025-06-20PCTUS2025034471RECOMBINANT ALPHA-GALACTOSIDASE A PROTEINS AND GENE THERAPYAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
TOBIAS WILLER
United States
2025-06-0219134958METHODS FOR TREATING LATE ONSET POMPE DISEASE IN PEDIATRIC PATIENTSAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260207718A1
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
CENTRAL, DOCKET
2025-06-0219134954METHODS FOR TREATING INFANTILE-ONSET POMPE DISEASE IN PEDIATRIC PATIENTSAmicus Therapeutics, Inc.Application Undergoing Preexam ProcessingUS20260207717A1
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2025-04-2119184366Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260097027A1
Jeff Castelli
Elfrida Benjamin
United States
United States
CENTRAL, DOCKET
2025-04-1119176778HIGHLY PURIFIED BATCHES OF PHARMACEUTICAL GRADE 1-DEOXYGALACTONOJIRIMYCIN COMPOUNDSAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250236592A1
Kamlesh Sheth
Sergey Tesler
James Cartwright
Clive King
Wendy Cross
United States
United States
United Kingdom
United Kingdom
United Kingdom
CENTRAL, DOCKET
2025-01-1719029413Augmented Acid Alpha-Glucosidase For The Treatment Of Pompe DiseaseAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250381254A1
Hung V. Do
Richie Khanna
Russell Gotschall
United States
United States
United States
CENTRAL, DOCKET
2025-01-1719028827Highly Potent Acid Alpha-Glucosidase With Enhanced CarbohydratesAmicus Therapeutics, Inc.Non Final Action MailedUS20260015600A1
Russell Gotschall
Hung V. Do
United States
United States
MEAH, MOHAMMAD Y
2024-11-1118943360Recombinant Human Acid Alpha-GlucosidaseAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250057925A1
Hung V. Do
Russell Gotschall
Richie Khanna
Yi Lun
Hing Char
Sergey Tesler
Wendy Sunderland
Enrique Diloné
United States
United States
United States
United States
United States
United States
United States
United States
HOLLAND, PAUL J
2024-11-0518863111Methods for Treating Pompe DiseaseAmicus Therapeutics, Inc.Non Final Action MailedUS20260041744A1
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
LANKFORD JR, LEON B
2024-09-1963696627METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING RENAL IMPAIRMENTAmicus Therapeutics, Inc.Provisional Application Expired
Franklin Johnson
United States
2024-08-1918808596Disulfide Bond Stabilized Polypeptide Compositions And Methods Of UseAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250242057A1
Hung V. Do
Ce Feng Liu
United States
United States
CENTRAL, DOCKET
2024-06-2663664513Nitrosamine Compounds and Methods for Analyzing the SameAmicus Therapeutics, Inc.Provisional Application Expired
MOHAMMED OSMAN SHEIKH
United States
2024-06-2063662097RECOMBINANT ALPHA-GALACTOSIDASE A PROTEINS AND GENE THERAPYAmicus Therapeutics, Inc.Provisional Application Expired
Tobias Willer
United States
2024-05-1018709210Compositions And Methods For Treating Mucopolysaccharidosis IIIAAmicus Therapeutics, IncNon Final Action MailedUS20250034533A1
Leida Rassouli-Taylor
Hung V. Do
Steven Tuske
Nastry Brignol
United States
United States
United States
United States
ROGERS, ERIC JASON
2024-01-12PCTUS2024011449GENE THERAPY CONSTRUCTS FOR THE TREATMENT OF POMPE DISEASEAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
HUNG V. DO
Panama
2024-01-1118578483Methods of Treating Fabry Disease in Pediatric PatientsAmicus Therapeutics, Inc.Non Final Action MailedUS20240293387A1
Franklin Johnson
United States
PECKHAM, RICHARD GRANT
2023-12-2918575512Neurotensin Variants And Tagged Proteins Comprising Neurotensin Or Sortilin PropeptideAmicus Therapeutics, Inc.Non Final Action Counted, Not Yet MailedUS20240318157A1
Helen Eisenach
Steven Tuske
United States
United States
REYNOLDS, FRED H
2023-12-01PCTUS2023082103METHODS FOR TREATING INFANTILE-ONSET POMPE DISEASE IN PEDIATRIC PATIENTSAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JAY BARTH
SHEELA SITARAMAN DAS
JEFF CASTELLI
United States
United States
United States
2023-12-01PCTUS2023082073METHODS FOR TREATING LATE ONSET POMPE DISEASE IN PEDIATRIC PATIENTSAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JAY BARTH
SHEELA SITARAMAN DAS
JEFF CASTELLI
United States
United States
United States
2023-10-0218479396METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENEAmicus Therapeutics, Inc.Non Final Action MailedUS20240277687A1
Elfrida Benjamin
United States
BRAUN, MADELINE E
2023-09-2518473622Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA GeneAmicus Therapeutics, Inc.Non Final Action MailedUS20240293436A1
Elfrida Benjamin
Xiaoyang Wu
United States
United States
NOAKES, SUZANNE MARIE
2023-08-1118276954Recombinant Human Acid Alpha-Glucosidase and Uses ThereofAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20240197839A1
Hung V. Do
Russell Gotschall
Hing Char
Jay Barth
United States
United States
United States
United States
BERKE-SCHLESSEL, DAVID W
2023-07-1718222745Dosing Regimens For The Treatment Of Fabry DiseaseAmicus Therapeutics, Inc.Notice of Appeal FiledUS20240115708A1
Douglas Stuart Greene
Kenneth Valenzano
United States
United States
MOSS, NATALIE M
2023-05-31PCTUS2023067656METHODS OF IMPROVING THE PHARMACOKINETICS OF MIGALASTATAMICUS THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
FRANKLIN JOHNSON
United States
KIM, HARRY CHONG HYUN
2023-05-05PCTUS2023066657METHODS FOR TREATING POMPE DISEASEAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JAY BARTH
SHEELA SITARAMAN DAS
JEFF CASTELLI
United States
United States
United States
2023-03-0363449810METHODS FOR TREATING INFANTILE-ONSET POMPE DISEASE IN PEDIATRIC PATIENTSAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2023-02-2163447222METHODS FOR TREATING POMPE DISEASEAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2023-02-1718111321Highly Potent Acid Alpha-Glucosidase With Enhanced CarbohydratesAmicus Therapeutics, Inc.Non Final Action MailedUS20230203465A1
Russell Gotschall
Hung V. Do
United States
United States
MEAH, MOHAMMAD Y
2023-02-0718040866Vesicle Targeting Proteins And Uses Of SameAmicus Therapeutics, Inc.Non Final Action MailedUS20240043494A1
Joseph Bauman
Xiaoyang Wu
Yuliya McAnany
United States
United States
United States
LOUNTOS, GEORGE THEMISTOCLIS
2023-01-1363438960Gene Therapy Constructs for the Treatment of Pompe DiseaseAmicus Therapeutics, Inc.Provisional Application Expired
Hung V. Do
United States
2022-12-2263434791METHODS FOR TREATING POMPE DISEASEAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2022-12-1363432235Methods of Improving the Pharmacokinetics of MigalastatAmicus Therapeutics, Inc.Provisional Application Expired
Franklin Johnson
United States
2022-12-1263431920METHODS FOR TREATING POMPE DISEASEAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2022-12-0263429969Methods for Treating Infantile-Onset Pompe Disease in Pediatric PatientsAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2022-12-0263429966Methods for Treating Late Onset Pompe Disease in Pediatric PatientsAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2022-11-3063428970METHODS FOR TREATING POMPE DISEASEAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2022-11-11PCTUS2022079716COMPOSITIONS AND METHODS FOR TREATING MUCOPOLYSACCHARIDOSIS IIIAAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
LEIDA RASSOULI-TAYLOR
HUNG DO
STEVEN TUSKE
NASTRY BRIGNOL
United States
United States
United States
United States
2022-11-0718053160GENE THERAPY CONSTRUCTS AND METHODS OF USEAmicus Therapeutics, Inc.Notice of Allowance Mailed -- Application Received in Office of PublicationsUS20230233711A1
Hung V. Do
Steven Tuske
Russell Gotschall
Ce Feng Liu
United States
United States
United States
United States
HASAN, KHALEDA B
2022-10-1063414897Methods for Treating Pompe DiseaseAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2022-10-07PCTUS2022077760BIOMARKERS FOR LYSOSOMAL STORAGE DISEASESAMICUS THERAPEUTICS, INC.
SANFORD HEALTH
RO PROCESSING COMPLETED-PLACED IN STORAGE
JON BRUDVIG
JILL WEINER
TYLER JOHNSON
JACOB CAIN
DEREK TIMM
United States
United States
United States
United States
United States
2022-09-0763404475Methods for Treating Pompe DiseaseAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2022-09-0617909450Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA GeneAmicus Therapeutics, Inc.Non Final Action MailedUS20230136297A1
Elfrida Benjamin
Xiaoyang Wu
United States
United States
INAM, SAHAR
2022-08-1963399498Methods for Treating Pompe DiseaseAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2022-08-1963399491Methods for Treating Pompe DiseaseAmicus Therapeutics, Inc.Provisional Application Expired
Jay Barth
Sheela Sitaraman Das
Jeff Castelli
United States
United States
United States
2022-08-09PCTUS2022039763DETERMINATION OF GENE TRANSDUCTION POTENCY IN NEURON-LIKE CELLSAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JACOB CAIN
SEAN SULLIVAN
United States
United States
2022-07-12PCTUS2022073626METHODS OF TREATING FABRY DISEASEAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
FRANKLIN JOHNSON
United States
2022-07-01PCTUS2022073333NEUROTENSIN VARIANTS AND TAGGED PROTEINS COMPRISING NEUROTENSIN OR SORTILIN PROPEPTIDEAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
STEVEN TUSKE
HELEN EISENACH
United States
United States
2022-06-1317838820Use Of Migalastat For Treating Fabry Disease In Pregnant PatientsAmicus Therapeutics, Inc.Notice of Appeal FiledUS20220387462A1
Jay Barth
United States
CRAIGO, BAHAR ALAWI
2022-06-1317838741Recombinant Alpha-Galactosidase A For Treatment Of Fabry DiseaseAmicus Therapeutics, Inc.Final Rejection MailedUS20230158123A1
Russell Gotschall
United States
STEADMAN, DAVID J
2022-05-1363341693COMPOSITIONS USEFUL IN TREATMENT OF CDKL5 DEFICIENCY DISORDER (CDD)Amicus Therapeutics, Inc.
The Trustees of the University of Pennsylvania
Provisional Application Expired
Ralf Schmid
Justin Percival
Evan Katz
Sean Clark
United States
United States
United States
United States
2022-05-0563338601METHODS FOR TREATING POMPE DISEASEAmicus Therapeutics, Inc.Provisional Application Expired
Jay BARTH
Sheela Sitaraman DAS
Jeffrey P. CASTELLI
United States
United States
United States
2022-04-2917773416Recombinant CDKL5 Proteins, Gene Therapy and Production MethodsAmicus Therapeutics, Inc.Non Final Action MailedUS20230043046A1
Sean Clark
Sean Sullivan
Hilary Gray
United States
United States
United States
NGUYEN, QUANG
2022-04-0817767803VARIANT IGF2 CONSTRUCTSAmicus Therapeutics, Inc.Response to Non-Final Office Action Entered and Forwarded to ExaminerUS20240091321A1
Hung V. Do
Steven Tuske
Russell Gotschall
Ce Feng Liu
United States
United States
United States
United States
WEHBE, ANNE MARIE SABRINA
2022-03-0417640456Method For Capturing And Purification Of BiologicsAmicus Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20230220320A1
Kumar Dhanasekharan
Christine Caroselli
Paul Langevin
United States
United States
United States
AFREMOVA, VERA
2022-02-11PCTUS2022016124RECOMBINANT HUMAN ACID ALPHA-GLUCOSIDASE AND USES THEREOFAMICUS THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
HUNG DO
RUSSELL GOTSCHALL
HING CHAR
JAY BARTH
United States
United States
United States
United States
KIM, HARRY CHONG HYUN
2022-02-04PCTUS2022015228ADENO-ASSOCIATED VIRUS DELIVERY OF CLN3 POLYNUCLEOTIDEAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
MITCHELL GOLDMAN
United States
2021-12-16PCTUS2021063653HIGHLY PURIFIED BATCHES OF PHARMACEUTICAL GRADE 1-DEOXYGALACTONOJIRIMYCIN COMPOUNDSAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
SERGEY TESLER
KAMLESH SHETH
United States
United States
2021-12-1363288911COMPOSITIONS USEFUL IN TREATMENT OF CDKL5 DEFICIENCY DISORDER (CDD)Amicus Therapeutics, Inc.
The Trustees of the University of Pennsylvania
Provisional Application Expired
Ralf Schmid
Justin Percival
Evan Katz
Sean Clark
United States
United States
United States
United States
2021-12-1017618277Methods Of Treating Fabry Disease In Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Notice of Appeal FiledUS20220313670A1
Franklin Johnson
United States
WHITE, DAWANNA SHAR-DAY
2021-11-1263278775GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS III AAmicus Therapeutics, Inc.
The Trustees of the University of Pennsylvania
Provisional Application Expired
Juliette Hordeaux
James M. Wilson
Leida Rassouli-Taylor
Hung Do
Steven Tuske
United States
United States
United States
United States
United States
2021-11-1263278626COMPOSITIONS AND METHODS FOR TREATING MUCOPOLYSACCHARIDOSIS IIIAAmicus Therapeutics, Inc.Provisional Application Expired
Leida RASSOULI-TAYLOR
Hung DO
Steven TUSKE
Nastry BRIGNOL
United States
United States
United States
United States
2021-11-0163274351COMPOSITIONS USEFUL IN TREATMENT OF CDKL5 DEFICIENCY DISORDER (CDD)Amicus Therapeutics, Inc.
The Trustees of the University of Pennsylvania
Provisional Application Expired
Ralf Schmid
Justin Percival
Evan Katz
Sean Clark
United States
United States
United States
United States
2021-09-2763248756ADENO-ASSOCIATED VIRUS DELIVERY OF CLN3 POLYNUCLEOTIDEAmicus Therapeutics, Inc.Provisional Application Expired
Mitch Goldman
United States
2021-08-0963230919Determination Of Gene Transduction Potency In Neuron-Like CellsAmicus Therapeutics, Inc.Provisional Application Expired
Jacob Cain
Sean Sullivan
United States
United States
2021-08-06PCTUS2021045012VESICLE TARGETING PROTEINS AND USES OF SAMEAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JOSEPH BAUMAN
YULIYA MCANANY
XIAOYANG WU
United States
United States
United States
2021-07-2217424979USE OF MIGALOSTAT IN REDUCING THE RISK OF CEREBROVASCULAR EVENT IN PATIENTS WITH FABRY DISEASEAmicus Therapeutics, Inc.Final Rejection MailedUS20220087993A1
Nina Skuban
Hjalmar Lagast
United States
United States
LEE, CHIHYI NMN
2021-07-1263220816METHODS OF TREATING FABRY DISEASEAmicus Therapeutics, Inc.Provisional Application Expired
Franklin Johnson
United States
2021-07-0163217500NEUROTENSIN VARIANTS AND TAGGED PROTEINS COMPRISING NEUROTENSIN OR SORTILIN PROPEPTIDEAmicus Therapeutics, Inc.Provisional Application Expired
Helen Eisenach
Steven Tuske
United States
United States
2021-05-14PCTUS2021032451COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASEAMICUS THERAPEUTICS, INC.
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
PCT - International Search Report Mailed to IB
JAMES M. WILSON
JULIETTE HORDEAUX
STEVEN TUSKE
RUSSELL GOTSCHALL
HUNG V. DO
United States
United States
United States
United States
United States
KIM, HARRY CHONG HYUN
2021-04-2763180379COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASEAmicus Therapeutics, Inc.
The Trustees of the University of Pennsylvania
Provisional Application Expired
James M. Wilson
Juliette Hordeaux
Hung V. Do
Russell Gotschall
Steven Tuske
United States
United States
United States
United States
United States
2021-03-1863162683RECOMBINANT HUMAN ACID ALPHA-GLUCOSIDASE AND USES THEREOFAMICUS THERAPEUTICS, INC.Provisional Application Expired
Hung DO
Russell GOTSCHALL
Hing CHAR
Jay BARTH
United States
United States
United States
United States
2021-03-1263160215Vesicle Targeting Proteins And Uses Of SameAmicus Therapeutics, Inc.Provisional Application Expired
Joseph Bauman
Xiaoyang Wu
Yuliya McAnany
United States
United States
United States
2021-03-05PCTUS2021020984METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENEAMICUS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
XIAOYANG WU
ELFRIDA BENJAMIN
United States
United States
2021-02-1163148596RECOMBINANT HUMAN ACID ALPHA-GLUCOSIDASE AND USES THEREOFAMICUS THERAPEUTICS, INCProvisional Application Expired
Hung DO
Russell GOTSCHALL
Hing CHAR
Jay BARTH
United States
United States
United States
United States
2021-02-10PCTUS2021017446METHODS OF TREATING FABRY DISEASEAMICUS THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
NINA SKUBAN
United States
THOMAS, SHANE M
2021-02-1017172846Methods Of Treating Fabry DiseaseAmicus Therapeutics, Inc.Notice of Allowance Mailed -- Application Received in Office of PublicationsUS20210251972A1
Nina Skuban
United States
JAVANMARD, SAHAR
2021-02-0563146110ADENO-ASSOCIATED VIRUS DELIVERY OF CLN3 POLYNUCLEOTIDEAmicus Therapeutics, Inc.Provisional Application Expired
Mitchell Goldman
United States
2020-08-0763062844Vesicle Targeting Proteins And Uses Of SameAmicus Therapeutics, Inc.Provisional Application Expired
Joseph Bauman
Xiaoyang Wu
Yuliya McAnany
United States
United States
United States
2017-06-2662524692Recombinant Alpha-Galactosidase A For Treatment Of Fabry DiseaseAmicus Therapeutics, Inc.Provisional Application Expired
Russell Gotschall
United States
2017-01-1062444578Recombinant Alpha-Galactosidase A For Treatment Of Fabry DiseaseAmicus Therapeutics, Inc.Provisional Application Expired
Russell Gotschall
United States